
Mettler-Toledo (MTD) Stock Forecast & Price Target
Mettler-Toledo (MTD) Analyst Ratings
Bulls say
Mettler-Toledo International is poised for continued growth, supported by an expected adjusted EPS increase of 6-8%, reflecting improved performance relative to previous estimates. The company shows operational strength with a slight expansion in adjusted operating margins and notable growth in service sales, indicating a robust service portfolio. Furthermore, the outlook for the pharmaceutical sector in the Americas and impressive growth in the food retail segment signal positive momentum, suggesting potential upside to market expectations for upcoming fiscal periods.
Bears say
Mettler-Toledo Intl's outlook reflects significant challenges, particularly in its China segment, where sales plummeted 25% in the third quarter, exacerbating concerns about ongoing weakness in this critical market. Additionally, the overall lab sales declined by 9%, driven by lowered demand in bioprocessing and consistent destocking in pipettes, signaling potential long-term headwinds in customer spending. With anticipated declines across multiple segments, including a mid-20s percentage drop in Food Retail for the third quarter and a forecasted 10% decrease in the Lab segment for the fourth quarter, Mettler-Toledo faces hurdles that could hinder revenue growth moving forward.
This aggregate rating is based on analysts' research of Mettler-Toledo and is not a guaranteed prediction by Public.com or investment advice.
Mettler-Toledo (MTD) Analyst Forecast & Price Prediction
Start investing in Mettler-Toledo (MTD)
Order type
Buy in
Order amount
Est. shares
0 shares